Petros Pharmaceuticals, Inc. Interest Expense, Related Party
Petros Pharmaceuticals, Inc. (PTPI) reported Interest Expense, Related Party of $596.02 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseRelatedParty · last filed 2023-03-31
- Petros Pharmaceuticals, Inc. interest expense, related party for the quarter ending 2020-12-31 was $579.01K.
- Petros Pharmaceuticals, Inc. interest expense, related party for the quarter ending 2020-09-30 was $669.73K.
- Petros Pharmaceuticals, Inc. interest expense, related party for the quarter ending 2020-06-30 was $402.44K.
- Petros Pharmaceuticals, Inc. interest expense, related party for the quarter ending 2020-03-31 was $76.28K.
- Petros Pharmaceuticals, Inc. interest expense, related party for fiscal 2022 was $596.02K.
- Petros Pharmaceuticals, Inc. interest expense, related party for fiscal 2020 was $1.73M.
| Period end | Interest Expense, Related Party 3 month | Interest Expense, Related Party 6 month | Interest Expense, Related Party 9 month | Interest Expense, Related Party 12 month |
|---|---|---|---|---|
| 2022-12-31 | $596.02K 10-K · filed 2023-03-31 | |||
| 2020-12-31 | $579.01K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $1.25M derived: sum of 2 quarters · filed 2022-03-31 | $1.65M derived: sum of 3 quarters · filed 2022-03-31 | $1.73M 10-K · filed 2022-03-31 |
| 2020-09-30 | $669.73K 10-Q · filed 2021-11-15 | $1.07M derived: sum of 2 quarters · filed 2021-11-15 | $1.15M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $402.44K 10-Q · filed 2021-08-16 | $478.72K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $76.28K 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |